Equity incl. NCI
Balance – as of period end · $M
Q1 2024
288$M
All values (41)
| Period | Value ($M) | Status |
|---|---|---|
| Q1 2026 | −1.167 | reported |
| Q4 2025 | 310 | reported |
| Q3 2025 | 378 | reported |
| Q2 2025 | 313 | reported |
| Q1 2025 | 124 | reported |
| Q4 2024 | 105 | reported |
| Q3 2024 | 305 | reported |
| Q2 2024 | 435 | reported |
| Q1 2024 | 288 | reported |
| Q4 2023 | 322 | reported |
| Q3 2023 | 395 | reported |
| Q2 2023 | 306 | reported |
| Q1 2023 | 80 | reported |
| Q4 2022 | 1,768 | reported |
| Q3 2022 | 2,006 | reported |
| Q2 2022 | 2,370 | reported |
| Q1 2022 | 2,676 | reported |
| Q4 2021 | 2,842 | reported |
| Q3 2021 | 2,734 | reported |
| Q2 2021 | 2,770 | reported |
| Q1 2021 | 2,772 | reported |
| Q4 2020 | 2,698 | reported |
| Q3 2020 | 2,421 | reported |
| Q2 2020 | 2,176 | reported |
| Q1 2020 | 2,080 | reported |
| Q4 2019 | 2,261 | reported |
| Q3 2019 | 2,064 | reported |
| Q2 2019 | 2,211 | reported |
| Q1 2019 | 2,170 | reported |
| Q4 2018 | 2,071 | reported |
| Q3 2018 | 2,141 | reported |
| Q2 2018 | 2,074 | reported |
| Q1 2018 | 2,184 | reported |
| Q4 2017 | 1,925 | reported |
| Q3 2017 | 1,673 | reported |
| Q2 2017 | 1,466 | reported |
| Q1 2017 | 1,386 | reported |
| Q4 2016 | 1,332 | reported |
| Q3 2016 | 1,475 | reported |
| Q2 2016 | 1,450 | reported |
| Q1 2016 | 1,290 | reported |
CSV with all sources · Technical ID: equity_total
More metrics for Verisk
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Operating income by segment
Sources & calculation
- Value
- $288M
- Period
- Q1 2024, ended Mar 31, 2024 · as of Mar 31, 2024 (balance as of date, not a sum)
- Source
- 10-Q, filed May 1, 2024 · 0001437749-24-014064
- Location
- us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $288M | May 1, 2024 | 10-Q 0001437749-24-014064 | reported · confidence 1. · current |